Commonwealth Equity Services’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.8K Sell
1,275
-100
-7% -$2.23K ﹤0.01% 4376
2026
Q1
$36.1K Buy
1,375
+391
+40% +$49.2K ﹤0.01% 4225
2025
Q4
$244K Buy
984
+451
+85% +$103K ﹤0.01% 3818
2025
Q3
$112K Buy
533
+92
+21% +$16.2K ﹤0.01% 4068
2025
Q2
$43K Sell
441
-85
-16% -$7.42K ﹤0.01% 4165
2025
Q1
$46K Buy
526
+95
+22% +$8.79K ﹤0.01% 4073
2024
Q4
$31K Hold
431
– – ﹤0.01% 4017
2024
Q3
$34K Buy
431
+41
+11% +$3.15K ﹤0.01% 3965
2024
Q2
$28K Sell
390
-196
-33% -$11.7K ﹤0.01% 3948
2024
Q1
$55K Sell
586
-13
-2% -$1.15K ﹤0.01% 3880
2023
Q4
$44K Buy
+599
New +$35.4K ﹤0.01% 3769

Other funds holding GOSS

Commonwealth Equity Services's GOSS Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Gossamer Bio (GOSS) stake by 7.3% in Q2 2026, selling an estimated $2.23K and leaving 1,275 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4376.

Commonwealth Equity Services first reported a position in GOSS in Q4 2023 and has held it in 11 quarters since. The position peaked at $244K in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Commonwealth Equity Services held 1,275 shares of Gossamer Bio worth $16.8K as of Q2 2026.
  • Commonwealth Equity Services sold 100 Gossamer Bio shares in Q2 2026, an estimated $2.23K.
  • Gossamer Bio made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4376 holding.
  • Commonwealth Equity Services first reported a position in Gossamer Bio in Q4 2023 and has held it in 11 quarters since.
  • Commonwealth Equity Services's Gossamer Bio position peaked at $244K in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.